|
| Exchange Disseminated Time | Jubilant Life Sciences Ltd has announced the following results for the quarter ended September 30, 2014:
"The Unaudited Standalone results for the Quarter ended September 30, 2014
The Company has posted a net profit of Rs. 2167.60 million for the quarter ended September 30, 2014 where as the same was at net loss of Rs. (785.80) million for the quarter ended September 30, 2013. Total Income is Rs. 7530.30 million for the quarter ended September 30, 2014 where as the same was at Rs. 9350.80 million for the quarter ended September 30, 2013.
- Previous period figures have been reclassified to conform to the current period's classification. Further, the figure for the current period are not comparable to the previous periods due to transfer of certain business."
The Consolidated Results are as follows:
The Unaudited Consolidated results for the Quarter ended September 30, 2014
The Group has posted a net profit/(loss) after taxes, minority interest and share in profit/(loss) of associates of Rs. (941.10) million for the quarter ended September 30, 2014 as compared to net loss of Rs. (805.80) million for the quarter ended September 30, 2013. Total Income has decreased from Rs. 14412.50 million for the quarter ended September 30, 2013 to Rs. 13975.20 million for the quarter ended September 30, 2014. |
|
|